Febrile neutropenia : Empiric antimicrobialtherapy during the last two decades;La neutropénie fébrile : L'antibiothérapie empirique de 1975 à 1997

Revue Medicale de Bruxelles

Volumn 18, Issue 5, 1997, Pages 323-327

  Klastersky, J ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; IMIPENEM; MEROPENEM; THIENAMYCIN DERIVATIVE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; GLYCOPEPTIDE;

BACTERIAL INFECTION; DRUG COMBINATION; FEVER; GRAM NEGATIVE INFECTION; HUMAN; NEUTROPENIA; REVIEW; SEPSIS; ANTIMICROBIAL THERAPY; GRAM NEGATIVE SEPSIS; GRAM POSITIVE BACTERIUM; INFECTION;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CEFTAZIDIME; CEPHALOSPORINS; DRUG THERAPY, COMBINATION; FEVER; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMIPENEM; NEUTROPENIA; SEPSIS; THIENAMYCINS;

EID: 0030832617     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Schimpff S, Satterlee W, Young WM : Empirical therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 284. 1061-1065, 1971
2. Klastersky J, Zinner S : Synergistic combinations of antibiotics in gram-negative bacillary infection Rev Infect Dis 1 294-301, 1982
3. EORTC International Antimicrobial Therapy Project Group : Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 137 : 14-29, 1978
4. EORTC International Antimicrobial Therapy Gooperative Group. Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients J Clin Oncol 1 : 597-603, 1983
5. Klastersky J, Glauser MP, Schimpff SC, for the Organization for Research on Treatment of Cancer Antimicrobial Therapy Group : Prospective randomized comparison of three antibiotic regimens of suspected bacteremic infection in febrile granulocytopenic patients. Antimicrob Agent Chemother 29 : 263-270, 1986
6. EORTC International Antimicrobial Therapy Project Group : Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 317 : 1692-1698, 1987
7. EORTC International Antimicrobial Therapy Project Group : Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. J Infect Dis 163 : 951-958, 1991
8. Attal M, Schlaifer D, Rubie H . Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin : a prospective randomized trial. J Clin Oncol 9 : 865-870, 1991
9. Elting LS, Bodey GP : Outcomes of bacteriemia in neutropenic cancer patients : influence of major organ or tissue infection. In : 7th International Symposium Supportive Care in Cancer, Luxembourg. Support Gare Cancer 3 331-383 abstract no2
10. Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia. A prospective, two-center validation of a prediction rule. J Clin Oncol 10: 316-322, 1992
11. EORTC International Antimicrobial Therapy Project Group Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med 119 : 584-593, 1993
12. Rubin M, Hathorn JW, Marshall D Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med 108 : 30-35, 1988
13. Cometta A, Zinner S, De Bock R : Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 39 : 415-152, 1995
14. Marie JP, Verkhoff A, Cony-Makhoul P, Fière D, Guy H, Herbrechet R, Milpied N, Pico JL, Planner I for the Study Group on Fever in Aplasia : Piperacillin / tazobactam + amikacin versus ceftazidime + amikacin in neutropenic patients with fever : an open muticenter trial. Presse Médicale 24 : 397-401, 1995
15. Cometta A, Calandra T, Gaya H, Zinner SH, de Bock R, Del Favero A, Bucaneve G, Crokaert F, Kern WV, Klastersky J, Langenaeken J, MICOZZI Z, Padmos A, Paesmans M, Viscoli C, Glauser MP and the International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologische Maligne dell'Adulto Infection Program : Monotherapy with meropenem versus combination therapy with cefrazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 40 : 1108-1115, 1996
16. De Pauw BE, Deresinski SC, Feld R for the Intercontinental Antimicrobial Study Group : Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. Ann Intern Med 120 : 834-844, 1994
17. Cordonnier C, Herbrecht R, Pico JL, Gardembas M, Delmer A, Delain M, Moreau Ph, Ladeb S, Nalet V, Rollin Ch, Gres JJ for the French Gefepime Study Group : Cefepime / Amikacin versus ceftazidime / amikacin as empirical therapy for febrile episodes in neutropenic patietns : a comparative study. J Infect Dis 24, 41-51, 1997
18. EORTC International Antimicrobial Therapy Project Group : Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 86 . 668-672, 1989
19. American Society of Clinical Oncology recommendations for the use of hemaropoietic colony-stimulating factors . Evidence-based, clinical practice guidelines J Clin Oncol 12 : 2471-2508, 1994